European Journal of Epidemiology

, Volume 14, Issue 1, pp 31–36

Prevalence, awareness, treatment, and control of hypertension in a Spanish population

  • Angel Puras
  • Carlos Sanchis
  • Luis M. Artigao
  • Juan A. Divison


A cross-sectional population survey using a random, stratified sample into phases was conducted in order to assess the prevalence, awareness, treatment, and control of hypertension in Albacete (a south-eastern province in Spain) with 248 000 inhabitants over 18 years of age. The sample size was of 1322 people. Both systolic and diastolic BP were higher in men than in women and showed an increasing trend with age independently of gender. Assuming a cut-off for hypertension of <140/90 mm Hg and <160/95 mm Hg, we found a prevalence of hypertension of 32.7% and 23.1%, respectively. Overall, 56.5% of hypertensive subjects were aware of their condition. The degree of this awareness was significantly higher in women and in the elderly. The percentage of patients who were receiving antihypertensive treatment was 49.1%. This proportion was also higher among women, elderly people, and subjects living in urban areas. High BP was successfully controlled in 10.9% of the total hypertensive population which accounted for 24.4% of the treated patients. The corresponding figures for the <160/95 mm Hg cut-off were 38.5% and 60.6%, respectively. In the logistic regression model, male gender and size of the local community were significantly associated with a better pharmacological control of hypertension. We found a high prevalence of hypertension with low degree of awareness and control, despite the general progress made in the diagnosis and treatment of hypertension in Spain. Specific intervention programs are necessary to increase the extent of control of hypertension in our country.

Awareness Control Cross-sectional study Hypertension 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    National Center for Health Statistics. Health, United States, 1992. Hyattsville, Maryland: Public Health Service, 1993.Google Scholar
  2. 2.
    Marmot M. Coronary heart disease: Rise and fall of a modern epidemic. In: Marmot M, Elliott P (eds), Coronary heart disease epidemiology: From aetiology to public health. Oxford, UK: Oxford University Press; 1992: 3–19.Google Scholar
  3. 3.
    Burt V, Cutler J, Higgins M, Horan M, Labarthe D, Whelton P, Brown C, Roccella E. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Hypertension 1995; 26: 60–69.PubMedGoogle Scholar
  4. 4.
    Nieto FJ, Alonso J, Chambless L, Zhong M, Ceraso M, Romm F, et al. Population awareness and control of hypertension and hypercholesterolemia. Arch Intern Med 1995; 155: 677–684.PubMedGoogle Scholar
  5. 5.
    Stockwell D, Madhavan S, Cohen H, Gibson G, Alderman M. The determinants of hypertension awareness, treatment and control in an insured population. Am J Public Health 1994; 84: 1768–1774.PubMedGoogle Scholar
  6. 6.
    Freeman V, Rotimi C, Cooper R. Hypertension, awareness, treatment and control among African Americans in the 1990s: Estimates from the Maywood Cardiovascular Survey. Am J Prev Med 1996; 12: 177–1785.PubMedGoogle Scholar
  7. 7.
    Gabriel R, Vega S, Suarez C. Prevalencia, conocimiento y control de la hipertensión arterial en la población anciana española: Resultados del estudio EPICARDIAN. Hipertensión 1996(suppl 1): 13–15.Google Scholar
  8. 8.
    Coca A. Control de la hipertensión arterial en España. Resultados del estudio Controlpres 95. Hipertensión 1995; 2: 182–188.Google Scholar
  9. 9.
    Liga Española para la Lucha contra la Hipertensión Arterial. Situación actual de la detección, tratamiento y control de la hipertensión en España. Madrid, 1995: 47.Google Scholar
  10. 10.
    Petrie J, O'Brien E, Littler W, de Swiet M. Recommendations of BP measurements. Br Med J [Clin Res] 1986; 293: 611–615.Google Scholar
  11. 11.
    Ministerior de Sanidad y Consumo. Consenso para el control de la hipertensióna arterial en España. Madrid, 1990.Google Scholar
  12. 12.
    Norusis M. SPSS/PC+ Advanced Statistics 4.0. Chicago: SPSS Inc., 1990.Google Scholar
  13. 13.
    Magrini F, Reggiani P. Epidemiology of hypertension in Europe. Eur Heart J 1992; 13(Suppl H): 27–34.PubMedGoogle Scholar
  14. 14.
    Batalla C, Blanquer A, Ciurana R, García M, Cases E, Pérez A. Cumplimiento de la prescripción farmacológica en pacientes hipertensos. Atención Primaria 1984; 11: 185–191.Google Scholar
  15. 15.
    Sociedad Española de Hipertensión-Liga Española para la lucha contra la Hipertensión Arterial. Observancia terapeútica en el paciente hipertenso. Madrid, 1996: 3–14.Google Scholar
  16. 16.
    Custodi J, Llor J, Farrus M, Vilaseca J, Zaera LL, Ribes E. La hipertensión arterial de la comarca del Baix Ebre. Hipertensión 1989; 6: 151–158.Google Scholar
  17. 17.
    Armario P, Hernandez R, Gasulla JM, Alonso A, Tresserras R, Pardell H. Prevalencia de hipertensión arterial en l'Hospitalet de Llobregat. Evolución de la tasa de control entre 1981 y 1987. Med Clin (Barc) 1990; 94: 570–575.Google Scholar
  18. 18.
    National Center for Health Statistics. Plan and operation of the Health and Nutrition Examination Survey, 1971– 73. Vital Health Stat 1977; 1(10): US Dept of Health and Human Services Publication (PHS), 79–1310.Google Scholar
  19. 19.
    McDowell A, Engle A, Massey J, Maurer K. Plan and operation of the second Health and Nutrition Examination Survey, 1976–80. Vital Health Stat 1981; 1(15): US Dept of Health and Human Services publication (PHS), 81–1317.Google Scholar
  20. 20.
    National Center for Health Statistics. Plan and operation of the Health and Nutrition Examination Survey, 1982– 84. Vital Health Stat 1985; 1(19): US Dept of Health and Human Services publication (PHS), 81–1321.Google Scholar
  21. 21.
    Gandía M, Redón J, Lozano J, Morales F, Rubio E. Evaluación del control del tratamiento antihipertensivo mediante el uso de monitorización ambulatoria de la presión arterial. Medic Clin (Barc) 1994; 103: 331–334.Google Scholar
  22. 22.
    Dannenberg A, Drizd T, Horan M, Haynes S, Leaverton P. Progresses in the battle against hypertension: Changes in BP levels in the United States from 1960 to 1980. Hypertension 1987; 10: 226–233.PubMedGoogle Scholar
  23. 23.
    Cooper R, Puras A, Tracy J, Kaufman J, Asuzu M, Ordunez P, Mufunda J, Sparks H. Evaluation of an electronic BP device for epidemiological studies. BP Monitoring 1997; 2: 35–40.Google Scholar
  24. 24.
    Schoenberger J, Stamler J, Shekelle R, Shekelle S. Current status of hypertension control in an industrial population. JAMA 1972; 222: 559–562.PubMedGoogle Scholar
  25. 25.
    Foote A, Erfurt J. Hypertension control at the work site: Comparison of screening and referral alone, referral and follow-up, and on-site treatment. N Engl J Med 1983; 308: 809–813.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1998

Authors and Affiliations

  • Angel Puras
    • 1
  • Carlos Sanchis
    • 2
  • Luis M. Artigao
    • 2
  • Juan A. Divison
    • 2
  1. 1.Department of Internal MedicineAlbacete General HospitalSpain
  2. 2.Primary Care Centre, InsaludAlbaceteSpain

Personalised recommendations